Product Information

FELBAMATE 400 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.8512 per EA under NDC 51672418501. Its NADAC has been published 466 times since Dec 13, 2017.

FDA first approved this application on Apr 20, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FELBAMATE 400 MG TABLET

Felbamate
$0.8512per EA

Strength

400 mg/1

NDC

51672418501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FELBAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207093

FDA Approved

4/20/2017

TE Code

AB

On Market Since

4/20/2017

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for FELBAMATE 400 MG TABLET has been published 466 times since Dec 13, 2017, and over the history we have for it it has declined 74.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8512 per EA
All-time high$3.2983 (Dec 13, 2017)
All-time low$0.6785 (Jul 22, 2026)
52-week high$1.0259
52-week low$0.6785
Median price$1.1756
Average price$1.7187
Largest weekly change-59.2% (Oct 21, 2020)
Weeks tracked466
Tracking sinceDec 13, 2017

Price History

1W

0.0%

1M

+6.7%

3M

+25.5%

6M

+5.5%

1Y

-17.5%

3Y

-21.6%

5Y

-27.6%

All

-74.2%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FELBAMATE 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.8512 per EA (NDC 51672418501), effective Nov 11, 2026.

How has the price of FELBAMATE 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 74.2%. It has been tracked across 466 weekly CMS publications since Dec 13, 2017.

What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?

Since Dec 13, 2017, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.6785 (Jul 22, 2026) to a high of $3.2983 (Dec 13, 2017), with a median of $1.1756 per EA.

Are there cheaper alternatives to FELBAMATE 400 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELBAMATE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FELBAMATE 400 MG TABLET?

FELBAMATE 400 MG TABLET (NDC 51672418501) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.